Sun Pharma announces settlement of patent litigation for generic Revlimid in the US
Pursuant to the terms of the settlement, Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
patent litigation
Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene
Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US
Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…